Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22

Trial Status

Completed2

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT01273207Phase 2Completed
Extension Study (Extended Access) of Cyclosporine Inhalation Solution (CIS) in Lung Transplant and Hematopoietic Stem Cell Transplant Recipients for the Treatment of Bronchiolitis Obliterans
Bronchiolitis ObliteransBronchiolitis, ExudativeBronchiolitis, Proliferative+3 more
PrincipalinvestigatorStart date: 2012-03-02
NCT01287078Phase 2Completed
Cyclosporine Inhalation Solution (CIS) in Lung Transplant and Hematopoietic Stem Cell Transplant Recipients for the Treatment of Bronchiolitis Obliterans Syndrome
Bronchiolitis ObliteransBronchiolitis, ExudativeBronchiolitis, Proliferative+2 more
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Ronald E Gress, M.D.

National Cancer Institute (NCI)

Related
10 trials

Shared therapeutic areas:

Bronchiolitis ObliteransGraft vs Host Disease
Similarity Score10%

Yi-Bin Chen, MD

Massachusetts General Hospital

Related
8 trials

Shared therapeutic areas:

Graft vs Host Disease
Similarity Score5%

Farid Boulad, MD

Memorial Sloan Kettering Cancer Center

Related
7 trials

Shared therapeutic areas:

Graft vs Host Disease
Similarity Score5%

A. John Barrett, M.D.

National Heart, Lung, and Blood Institute (NHLBI)

Related
7 trials

Shared therapeutic areas:

Graft vs Host Disease

Worked with same sponsors:

National Heart, Lung, and Blood Institute (NHLBI)
Similarity Score5%

Claudio G. Brunstein, MD, PhD

Masonic Cancer Center, University of Minnesota

Related
7 trials

Shared therapeutic areas:

Graft vs Host Disease

Worked with same sponsors:

National Heart, Lung, and Blood Institute (NHLBI)
Similarity Score5%

Christopher James, PA

Mesoblast, Inc.

Related
7 trials

Shared therapeutic areas:

Graft vs Host Disease
Similarity Score5%

Areej El-Jawahri, MD

Massachusetts General Hospital

Related
21 trials

Shared therapeutic areas:

Graft vs Host Disease
Similarity Score5%

Ryotaro Nakamura

City of Hope Medical Center

Related
10 trials

Shared therapeutic areas:

Graft vs Host Disease

Worked with same sponsors:

National Heart, Lung, and Blood Institute (NHLBI)
Similarity Score5%

William I. Bensinger, MD

Fred Hutchinson Cancer Center

Related
12 trials

Shared therapeutic areas:

Graft vs Host Disease
Similarity Score5%

Etienne Merlin

University Hospital, Clermont-Ferrand

Related
8 trials

Shared therapeutic areas:

Graft vs Host Disease
Similarity Score5%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT01273207Phase 2PrincipalInvestigator

Extension Study (Extended Access) of Cyclosporine Inhalation Solution (CIS) in Lung Transplant and Hematopoietic Stem Cell Transplant Recipients for the Treatment of Bronchiolitis Obliterans

Bronchiolitis ObliteransBronchiolitis, ExudativeBronchiolitis, Proliferative+3 more
Completed
NCT01287078Phase 2PrincipalInvestigator

Cyclosporine Inhalation Solution (CIS) in Lung Transplant and Hematopoietic Stem Cell Transplant Recipients for the Treatment of Bronchiolitis Obliterans Syndrome

Bronchiolitis ObliteransBronchiolitis, ExudativeBronchiolitis, Proliferative+2 more
Completed

All 2 trials loaded